HALO
NASDAQ · Biotechnology
Halozyme Therapeutics Inc
$62.04
-0.82 (-1.30%)
Performance
1D
—
1W
—
1M
—
3M
-9.92%
6M
-15.88%
1Y
-4.32%
YTD
-11.76%
Open$62.39
Previous Close$62.86
Day High$62.85
Day Low$61.49
52W High$82.22
52W Low$47.50
Volume—
Avg Volume2.46M
Market Cap8.40B
P/E Ratio14.11
EPS$4.76
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$71.23
Below
SMA 200
$65.75
Below
RSI (14)
47.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
15 analysts
Price Target
-66.1% upside
Current
$62.04
$62.04
Target
$21.02
$21.02
$15.29
$21.02 avg
$24.22
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 811.57M | 615.67M | 1.30B |
| Net Income | 354.97M | 242.36M | -74,995,325 |
| Profit Margin | 43.7% | 41.6% | -5.8% |
| EBITDA | 497.60M | 358.61M | -91,476,031 |
| Free Cash Flow | — | — | -86,399,966 |
| Rev Growth | +31.8% | +31.8% | +13.4% |
| Debt/Equity | 4.14 | 4.14 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |